Mobile app
development services
in Cambridge

Cambridge mobile opportunities span biotech mobile applications (patient-facing apps for therapeutic areas including Moderna mRNA vaccines, Biogen neurology including Alzheimer's and MS, Alnylam RNAi therapeutics for rare diseases, Editas and Beam gene editing patient programs, bluebird bio gene therapy patient support), academic mobile applications (Harvard and MIT campus apps, research collaboration tools, scholarly apps), tech industry mobile (HubSpot mobile ecosystem, Akamai SDK and developer tools), healthcare mobile (Cambridge Health Alliance, Mount Auburn Hospital patient engagement, telemedicine), and consumer mobile (Harvard Square retail, restaurant ordering, local services).

Cambridge demographics favor iOS substantially — Harvard and MIT student populations, Kendall Square biotech professionals, academic faculty, and Cambridge tech industry workers represent some of the highest iPhone-share populations globally with iOS share commonly 75-85% versus US average of 55-60%. We develop iOS native (Swift, SwiftUI), Android native (Kotlin, Jetpack Compose) for broader reach, cross-platform (React Native, Flutter) when economics favor unified codebase, and Progressive Web Apps for mobile web alternatives.

Mobile development timelines depend on scope substantially. MVP mobile apps with focused functionality on single platform deliver in 12-16 weeks. Standard mobile apps with reasonable feature scope on both platforms run 4-7 months. Comprehensive mobile applications with backend integration, sophisticated features, and enterprise requirements run 6-12 months. Biotech patient apps with FDA regulatory requirements (some apps qualify as Software as a Medical Device — SaMD) run 8-14 months with appropriate regulatory documentation. Academic apps with institutional integration run 6-10 months.

Biotech mobile applications require specialized engineering. Patient-facing apps for Moderna, Biogen, Alnylam, Editas, Beam, bluebird bio, and other Kendall Square biotech often qualify as Software as a Medical Device requiring FDA regulatory submission and 21 CFR Part 11 electronic records compliance. We engineer with proper regulatory documentation, HIPAA compliance for PHI handling, integration with biotech clinical systems, multilingual support for global biotech audiences, and accessibility for diverse patient populations.

Cambridge mobile apps accommodate Chinese-speaking users (substantial international student and biotech professional population — Simplified for mainland China, Traditional for Taiwan and Hong Kong), Korean-speaking users (substantial Cambridge Korean community), Japanese-speaking users, Hindi-speaking users (substantial Cambridge Indian community), Spanish-speaking users, Portuguese-speaking users (substantial Cambridge Brazilian academic community), French-speaking users, German-speaking users, and substantial other languages reflecting Cambridge's exceptionally international community with proper iOS and Android internationalization frameworks.

Mobile applications require robust backend infrastructure. We build with scalable cloud architecture (AWS, Google Cloud Platform, Azure depending on enterprise context), RESTful or GraphQL APIs supporting mobile clients, real-time capabilities using WebSocket or Firebase where appropriate, proper authentication using OAuth 2.0 with refresh token patterns, push notification infrastructure (APNs for iOS, FCM for Android), analytics integration (Firebase Analytics, Mixpanel, Amplitude), and crash reporting (Crashlytics, Sentry).

App Store and Google Play deployment involves substantial process. We handle App Store Connect and Google Play Console configuration, app metadata and screenshots optimized for store discoverability, review process navigation including responding to reviewer feedback (App Store reviewers often have substantial concerns about healthcare and biotech apps requiring careful response), staged rollout strategies, and ongoing store presence management. For Cambridge biotech apps with FDA regulatory requirements, additional documentation often accompanies store submissions.

Mobile applications require continuous operations. iOS and Android OS updates require app compatibility updates typically twice annually. Device compatibility expansion as new devices launch. Backend infrastructure operations and scaling. Security patching and incident response. Analytics monitoring and optimization. Crash monitoring and resolution. Feature evolution based on user feedback. App Store and Google Play presence management. Toimi provides Cambridge clients comprehensive mobile operations support.